The missing link between decompression and pedicle screws.
StabiLink® MIS Interlaminar Fixation — designed to bridge the treatment gap between decompression and more invasive pedicle screw constructs. FDA-cleared for single-level use, T1–S1.
Between two extremes lies an option many appropriate patients often never hear about.
For select lumbar spine patients, the gap between less-invasive care and more invasive constructs leaves a meaningful treatment opportunity. StabiLink was designed to address it.
Decompression Alone
StabiLink
Pedicle Screws
See it in person.
Live conversations with our clinical team at Becker's 2026, Booth 506.
A focused approach to interlaminar fixation.
Every aspect of StabiLink was engineered to address the gap between conservative care and more invasive constructs.
Designed to deliver fusion-grade stability
Engineered to provide supplemental fixation while supporting bony fusion.
90%+ CT-verified fusion*
Independent review of CT-assessed cases. Data on file, Southern Spine, LLC.
True lamina-based fixation
Designed to engage the lamina — not just the spinous process — for enhanced stability.
Less surgical trauma. Less dissection.
An MIS posterior approach designed for quicker recovery potential.
ASC-compatible
Same-day discharge potential — designed for outpatient surgical workflows.
FDA-cleared, T1–S1
Cleared for single-level use as a posterior, non-pedicle supplemental fixation device.
In clinical use since 2013
A decade-plus of real-world surgical use and refinement.
Preserves future options
A supplemental approach that doesn't preclude escalation if ever needed.
Backed by training & support
Training and onboarding support provided to qualified clinicians.
Used in more than 7,000 surgical procedures.
A decade-plus of real-world surgical use by spine surgeons performing supplemental interlaminar fixation — across community hospitals, academic centers, and ASCs.
Twenty minutes at the booth changes the conversation.
Reserve a time slot with our clinical team — June 11–13, Swissotel Chicago.
From pain management to pain solutions.
For pain physicians and ASC partners: when conservative care reaches its ceiling, StabiLink offers a structural pathway — designed for same-day discharge potential and ASC-compatible workflows.
Meet us at Becker's 2026.
Reserve a meeting time with our clinical and commercial team at Booth 506. Twenty focused minutes — designed for spine surgeons, pain physicians, and ASC partners who want a working understanding of where StabiLink fits.
Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine
Form goes here
Indications for Use
The StabiLink® MIS Spinal Fixation System is a posterior, non-pedicle supplemental fixation device, intended for use at a single level in the non-cervical spine (T1–S1). It is intended for plate fixation/attachment to spinous processes for the purpose of achieving supplemental fusion in the following conditions: degenerative disc disease (DDD) (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies); spondylolisthesis; trauma (i.e., fracture or dislocation); tumor. It is not intended for stand-alone use.
Important Safety Information
The safety and effectiveness of spinal fixation systems have been established only for spinal conditions with significant mechanical instability or deformity requiring fusion with instrumentation. The safety and effectiveness of these devices for any other conditions are unknown. A successful result is not always achieved in every surgical case.
Contraindications include, but are not limited to: allergy to titanium or foreign body sensitivity; known or suspected infection; severe osteoporosis or other conditions affecting bone remodeling; morbid obesity; pregnancy; incompetent or missing posterior arch (e.g., laminectomy, pars defect); among others.
Possible complications specific to the device may include early or late implant bending, breakage, failure, loosening, movement, or migration; bone and/or spinous process fracture; allergic reaction to implant material.
The StabiLink® device has not been evaluated for safety and compatibility in the magnetic resonance (MR) environment.
For complete indications, contraindications, warnings, precautions, and directions for use, please refer to the StabiLink® Instructions for Use (IFU).
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.